Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2003
09/12/2003WO2003074687A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074675A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
09/12/2003WO2003074667A2 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074568A1 Individualized anti-cancer antibodies
09/12/2003WO2003074564A1 Novel hemepeptide
09/12/2003WO2003074562A2 Vanilloid receptor (trpv) fusion proteins
09/12/2003WO2003074561A1 A method for treating allergic disease and asthma by recombinant adenovirus-and adeno-associated virus-mediated ifn-ϝ gene
09/12/2003WO2003074560A2 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto
09/12/2003WO2003074559A1 Falp proteins
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074556A1 Tumor tag and the use thereof
09/12/2003WO2003074555A2 Synthetic peptides from c. difficile
09/12/2003WO2003074554A2 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof
09/12/2003WO2003074547A2 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor
09/12/2003WO2003074543A1 Anti-protozoal vaccine
09/12/2003WO2003074089A1 Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof
09/12/2003WO2003074087A1 Coupling proteins to a modified polysaccharide
09/12/2003WO2003074084A1 A pharmaceutical composition
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003074077A1 Purification of red blood cells by separation and diafiltration
09/12/2003WO2003074076A2 Periocular drug delivery for diabetic retinopathy
09/12/2003WO2003074074A1 COMPOSITIONS COMPRISING Nm23 PROTEIN FOR THE USE OF MATRIX METALLOPROTEINASE INHIBITOR AND ANGIOGENESIS INHIBITOR
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074071A1 Remedies for liver diseases, hyperlipemia and diabetes
09/12/2003WO2003074070A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
09/12/2003WO2003074068A2 Use of soluble fgl2 as an immunosuppressant
09/12/2003WO2003074060A2 Dna demethylase antisense and chemotherapy combination
09/12/2003WO2003074057A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/12/2003WO2003074022A2 Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
09/12/2003WO2003074007A2 Modulators of leukocyte activation, compositions, and methods of use
09/12/2003WO2003074005A2 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/12/2003WO2003074004A2 Method of producing antigens
09/12/2003WO2003073998A2 Local production and/or delivery of anti-cancer agents by stromal cell precursors
09/12/2003WO2003073994A2 Methods of treating nerve entrapment syndromes
09/12/2003WO2003073991A2 Methods to increase or decrease bone density
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073982A2 Anti-interleukin-1 beta analogs
09/12/2003WO2003073981A2 Novel of cytokine inhibitors
09/12/2003WO2003073980A2 Recombinant protein c variants
09/12/2003WO2003073918A2 Prevention of recurrence and metastasis of cancer
09/12/2003WO2003066844A3 Cytochrome p450 protein
09/12/2003WO2003066674A3 Viral cd30 polypeptide
09/12/2003WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use
09/12/2003WO2003051389A3 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
09/12/2003WO2003051374A3 SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
09/12/2003WO2003047525A3 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
09/12/2003WO2003047524A3 Methods and compositions for modulating the immune system and uses thereof
09/12/2003WO2003044160A3 Novel molecules of the card related protein family and uses thereof
09/12/2003WO2003041757A3 Catheter injectable depot compositions and uses thereof
09/12/2003WO2003041684A3 Injectable depot compositions and uses thereof
09/12/2003WO2003038034A3 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary
09/12/2003WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity
09/12/2003WO2003035884A3 Transient immortalization
09/12/2003WO2003033027A3 Dendrimers for use in targeted delivery
09/12/2003WO2003033014A3 Novel use of pulmonary surfactant
09/12/2003WO2003031576A3 Antisense modulation of inhibitor-kappa b kinase-gamma expression
09/12/2003WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same
09/12/2003WO2003007794A3 Invasion complex and methods of targeting
09/12/2003WO2003003017A3 Use of transcription factor nak-1 or genes regulated by transcription factor nak-1 for the diagnosis and/or therapy of inflammatory and malignant diseases
09/12/2003WO2003000734A3 Ion channel modulators
09/12/2003WO2002102835A3 Novel antimicrobial compounds
09/12/2003WO2002090500A3 Novel human proteins, polynucleotides encoding them and methods of using the same
09/12/2003WO2002088314A3 Ovary-specific genes and proteins
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002066071A3 Treatment of tissue fibrosis by blocking the sp1 transcription factor
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002058732B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
09/12/2003WO2002054080A3 Proteins, genes and their use for diagnosis and treatment of vascular response
09/12/2003WO2002052011A3 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002048343A3 Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions
09/12/2003WO2002046391A3 Transgenic mice containing nori gene disruptions
09/12/2003WO2002040658A3 Isomerases
09/12/2003WO2002036616A3 Compositions and methods relating to breast specific genes and proteins
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002030447A3 Treatment of demyelinating diseases by administering gpe
09/12/2003WO2002030256A9 Diagnostic indicator of thymic function
09/12/2003WO2002018572A3 Membrane penetrating peptides and uses thereof
09/12/2003WO2002017956A3 Stabilized fgf formulations containing reducing agents
09/12/2003WO2002016591A9 Human transporter family members and uses thereof
09/12/2003WO2002010401A9 18431 and 32374, human protein kinase family members and uses therefor
09/12/2003WO2001095785A3 Modulation of immune response and methods based thereon
09/12/2003WO2001090197A9 Synthetic peptides and uses therefore
09/12/2003CA2818688A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
09/12/2003CA2666005A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478378A1 Novel use of cytokine inhibitors
09/12/2003CA2478171A1 Apoptogenic-bacteriocins combining broad spectrum antibiotic and selective anti-tumoral activities, and compositions and uses thereof
09/12/2003CA2478133A1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/12/2003CA2478124A1 Dna demethylase antisense and chemotherapy combination
09/12/2003CA2477969A1 Falp proteins
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477854A1 Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
09/12/2003CA2477836A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/12/2003CA2477816A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
09/12/2003CA2477808A1 Methods of treating nerve entrapment syndromes
1 ... 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 ... 3163